Bibliometric Analysis of PD-1/PD-L1 Inhibitor Resistance Research, 2006-2025

A bibliometric analysis of 2,122 studies on resistance to PD-1/PD-L1 inhibitors in cancer treatment, spanning from 2006 to 2025. The dataset was compiled by Lehan Miao from the Web of Science and Scopus databases and last updated in May 2026. China leads in publication volume, while the United States ranks second and has more international collaboration.

Use Cases

• Analyze publication trends and growth in PD-1/PD-L1 resistance research based on the 2006-2025 timeline
• Identify leading countries and institutions in the field based on publication volume and collaboration metrics
• Map research hotspots and emerging topics based on keyword and reference analysis mentioned in the description

Strengths

• Analysis is based on 2,122 studies, providing a substantial corpus for trend analysis
• Data covers a 20-year period from 2006 to 2025, allowing for longitudinal study
• Identifies specific leading entities such as Memorial Sloan Kettering Cancer Center and the Journal of Clinical Oncology

Limitations

• The dataset is a single DOCX file (708.4 KB), which suggests limited scope and may not contain the raw underlying bibliographic data
• Column-level documentation is absent; field semantics must be inferred after download
• Row count is unknown, which may limit suitability assessment for large-scale computational analysis

Provenance

Source

Documents retrieved from the Web of Science Core Collection and Scopus databases.

Collection Method

Systematic retrieval and analysis using bibliometric tools, followed by secondary screening and classification.

Time Range

January 1, 2006 to November 29, 2025

Freshness

Last updated 2026-05-28 06:20:19

Geography

Global, with specific mention of China and the United States leading in publications.